Qinghua Lu

3.2k total citations
70 papers, 1.9k citations indexed

About

Qinghua Lu is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Qinghua Lu has authored 70 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 19 papers in Cardiology and Cardiovascular Medicine and 12 papers in Surgery. Recurrent topics in Qinghua Lu's work include Cardiovascular Function and Risk Factors (7 papers), Cardiac Ischemia and Reperfusion (7 papers) and Coronary Interventions and Diagnostics (6 papers). Qinghua Lu is often cited by papers focused on Cardiovascular Function and Risk Factors (7 papers), Cardiac Ischemia and Reperfusion (7 papers) and Coronary Interventions and Diagnostics (6 papers). Qinghua Lu collaborates with scholars based in China, United States and Sweden. Qinghua Lu's co-authors include Xun Hu, Qiangrong Pan, Weidong Han, Jianhong Luo, Ying Gu, Shuang Qiu, Ling Li, Xiaowei Xing, Dong Xu and Mingxiang Zhang and has published in prestigious journals such as PLoS ONE, Cancer Research and Biochemical and Biophysical Research Communications.

In The Last Decade

Qinghua Lu

69 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qinghua Lu China 26 988 282 279 263 229 70 1.9k
Yangyang Hu China 20 869 0.9× 314 1.1× 171 0.6× 216 0.8× 320 1.4× 53 2.1k
Wu Luo China 26 1.3k 1.3× 198 0.7× 414 1.5× 244 0.9× 283 1.2× 92 2.5k
Zhou‐Yan Bian China 31 1.1k 1.1× 259 0.9× 739 2.6× 258 1.0× 189 0.8× 63 2.2k
Yuanyuan Zhang China 28 927 0.9× 342 1.2× 149 0.5× 249 0.9× 203 0.9× 102 2.4k
Tomonaga Ichikawa Japan 22 1.3k 1.3× 152 0.5× 296 1.1× 284 1.1× 264 1.2× 47 2.3k
Kyung‐Sun Heo South Korea 29 1.2k 1.2× 178 0.6× 180 0.6× 345 1.3× 231 1.0× 81 2.0k
Michelle C. McDonald United Kingdom 29 918 0.9× 372 1.3× 263 0.9× 146 0.6× 240 1.0× 40 2.4k
Yanjun Zheng China 23 803 0.8× 162 0.6× 135 0.5× 266 1.0× 244 1.1× 61 1.7k
Hui Cai China 26 954 1.0× 181 0.6× 113 0.4× 270 1.0× 172 0.8× 78 1.8k
Pengli Zhu China 15 684 0.7× 378 1.3× 123 0.4× 213 0.8× 165 0.7× 62 1.5k

Countries citing papers authored by Qinghua Lu

Since Specialization
Citations

This map shows the geographic impact of Qinghua Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qinghua Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qinghua Lu more than expected).

Fields of papers citing papers by Qinghua Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qinghua Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qinghua Lu. The network helps show where Qinghua Lu may publish in the future.

Co-authorship network of co-authors of Qinghua Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Qinghua Lu. A scholar is included among the top collaborators of Qinghua Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qinghua Lu. Qinghua Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kuang, Jiangying, Nana Huang, Jianchao Li, et al.. (2025). Shouhui Tongbian Capsule ameliorates obesity by enhancing energy consumption and promoting lipolysis via cAMP-PKA pathway. Phytomedicine. 138. 156375–156375. 2 indexed citations
2.
Kuang, Jiangying, Jian Chen, Kan Liu, et al.. (2025). Sacubitril/valsartan attenuates inflammation and myocardial fibrosis in Takotsubo-like cardiomyopathy. Journal of Molecular and Cellular Cardiology. 200. 24–39. 5 indexed citations
3.
Xing, Xiaowei, et al.. (2020). miR-26a-5p protects against myocardial ischemia/reperfusion injury by regulating the PTEN/PI3K/AKT signaling pathway. Brazilian Journal of Medical and Biological Research. 53(2). e9106–e9106. 88 indexed citations
4.
Zhang, Junjie, Xiaofei Gao, Zhen Ge, et al.. (2019). Impact of intravascular ultrasound‐guided drug‐eluting stent implantation on patients with chronic kidney disease: Results from ULTIMATE trial. Catheterization and Cardiovascular Interventions. 93(7). 1184–1193. 13 indexed citations
5.
6.
Wang, Qi, Tong Zhao, Wei Zhang, et al.. (2018). Poly (ADP-Ribose) Polymerase 1 Mediated Arginase II Activation Is Responsible for Oxidized LDL-Induced Endothelial Dysfunction. Frontiers in Pharmacology. 9. 882–882. 15 indexed citations
7.
Liu, Yanqiong, Li-Ying Huang, Lu Yu, et al.. (2015). Relationships between the Osteocalcin Gene Polymorphisms, Serum Osteocalcin Levels, and Hepatitis B Virus-Related Hepatocellular Carcinoma in a Chinese Population. PLoS ONE. 10(1). e0116479–e0116479. 4 indexed citations
8.
Meng, Kai, Qiutang Zeng, Qinghua Lu, et al.. (2015). Valsartan Attenuates Atherosclerosis via Upregulating the Th2 Immune Response in Prolonged Angiotensin II-Treated ApoE−/− Mice. Molecular Medicine. 21(1). 143–153. 27 indexed citations
9.
Huang, Zhiwei, et al.. (2015). Atorvastatin counteracts high glucose-induced Krüppel-like factor 2 suppression in human umbilical vein endothelial cells. Postgraduate Medicine. 127(5). 446–454. 6 indexed citations
10.
Wang, Juan, Hao Lin, Yan Wang, et al.. (2014). Inhibition of poly (ADP-ribose) polymerase and inducible nitric oxide synthase protects against ischemic myocardial damage by reduction of apoptosis. Molecular Medicine Reports. 11(3). 1768–1776. 20 indexed citations
11.
Huang, Zhiwei, et al.. (2014). The expression of epidermal growth factor-like domain 7 regulated by oxygen tension via hypoxia inducible factor (HIF)-1α activity. Postgraduate Medicine. 127(2). 144–149. 5 indexed citations
12.
Li, Ling, Weidong Han, Ying Gu, et al.. (2007). Honokiol Induces a Necrotic Cell Death through the Mitochondrial Permeability Transition Pore. Cancer Research. 67(10). 4894–4903. 92 indexed citations
13.
Han, Weidong, Ling Li, Shuang Qiu, et al.. (2007). Shikonin circumvents cancer drug resistance by induction of a necroptotic death. Molecular Cancer Therapeutics. 6(5). 1641–1649. 316 indexed citations
14.
Li, Ling, Qiangrong Pan, Meng Sun, Qinghua Lu, & Xun Hu. (2006). Dibenzocyclooctadiene lignans — A class of novel inhibitors of multidrug resistance-associated protein 1. Life Sciences. 80(8). 741–748. 41 indexed citations
15.
Zhong, Xian, Yongliang Zhu, Qinghua Lu, et al.. (2006). Silymarin causes caspases activation and apoptosis in K562 leukemia cells through inactivation of Akt pathway. Toxicology. 227(3). 211–216. 32 indexed citations
16.
Lu, Qinghua, et al.. (2005). [Plasma activated coagulation factor VII and Msp I polymorphism in elderly patients with coronary heart disease].. PubMed. 22(6). 691–3. 1 indexed citations
17.
Pan, Qiangrong, et al.. (2005). Schisandrin B—A novel inhibitor of P-glycoprotein. Biochemical and Biophysical Research Communications. 335(2). 406–411. 59 indexed citations
18.
Xu, Rongzhen, Qinghua Dong, Xiaoying Zhao, et al.. (2005). Berbamine: A novel inhibitor of bcr/abl fusion gene with potent anti-leukemia activity. Leukemia Research. 30(1). 17–23. 61 indexed citations
19.
Pan, Qiangrong, Qinghua Lu, Kun Zhang, & Xun Hu. (2005). Dibenzocyclooctadiene lingnans: a class of novel inhibitors of P-glycoprotein. Cancer Chemotherapy and Pharmacology. 58(1). 99–106. 51 indexed citations
20.
Zhang, Kun, Qinghua Lu, Qian Zhang, & Xun Hu. (2004). Regulation of activities of NK cells and CD4 expression in T cells by human HNP-1, -2, and -3. Biochemical and Biophysical Research Communications. 323(2). 437–444. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yangyang Hu Breakdown of academic impact, for papers by Wu Luo Breakdown of academic impact, for papers by Zhou‐Yan Bian Breakdown of academic impact, for papers by Yuanyuan Zhang Breakdown of academic impact, for papers by Tomonaga Ichikawa Breakdown of academic impact, for papers by Kyung‐Sun Heo Breakdown of academic impact, for papers by Michelle C. McDonald Breakdown of academic impact, for papers by Yanjun Zheng Breakdown of academic impact, for papers by Hui Cai Breakdown of academic impact, for papers by Pengli Zhu
Rankless by CCL
2026